JP6976691B2 - 医薬組成物 - Google Patents

医薬組成物 Download PDF

Info

Publication number
JP6976691B2
JP6976691B2 JP2017022803A JP2017022803A JP6976691B2 JP 6976691 B2 JP6976691 B2 JP 6976691B2 JP 2017022803 A JP2017022803 A JP 2017022803A JP 2017022803 A JP2017022803 A JP 2017022803A JP 6976691 B2 JP6976691 B2 JP 6976691B2
Authority
JP
Japan
Prior art keywords
group
fluoro
methoxy
dihydroquinoline
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017022803A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017141224A5 (enExample
JP2017141224A (ja
Inventor
洋 清水
芳和 川野
俊平 石川
幸崇 植松
俊夫 篠原
元宏 糸谷
佳和 原口
勲 竹村
篤謹 兼重
雄野 中井
徳充 播口
陽平 林
真 松本
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of JP2017141224A publication Critical patent/JP2017141224A/ja
Publication of JP2017141224A5 publication Critical patent/JP2017141224A5/ja
Application granted granted Critical
Publication of JP6976691B2 publication Critical patent/JP6976691B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2017022803A 2016-02-10 2017-02-10 医薬組成物 Active JP6976691B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016023873 2016-02-10
JP2016023873 2016-02-10

Publications (3)

Publication Number Publication Date
JP2017141224A JP2017141224A (ja) 2017-08-17
JP2017141224A5 JP2017141224A5 (enExample) 2020-02-27
JP6976691B2 true JP6976691B2 (ja) 2021-12-08

Family

ID=59627082

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017022803A Active JP6976691B2 (ja) 2016-02-10 2017-02-10 医薬組成物

Country Status (1)

Country Link
JP (1) JP6976691B2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023085582A (ja) * 2020-05-11 2023-06-21 大塚製薬株式会社 ジヒドロキノリノン化合物の共結晶
CN116102537B (zh) * 2021-11-10 2024-10-01 四川大学 一种喹啉酮类衍生物及其制备方法和用途
CN116589448B (zh) * 2023-04-24 2025-10-28 西南交通大学 一种3,4-二氢喹啉酮衍生物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0812648D0 (en) * 2008-07-10 2008-08-20 Prosidion Ltd Compounds

Also Published As

Publication number Publication date
JP2017141224A (ja) 2017-08-17

Similar Documents

Publication Publication Date Title
JP6625612B2 (ja) 二環式複素環化合物及びその結核治療用途
JP6014148B2 (ja) ヤヌスキナーゼ阻害剤としてのシクロアルキルニトリルピラゾールカルボキサミド
TWI864071B (zh) 2-羥環烷-1-胺甲醯基衍生物
KR20220154174A (ko) Yap/taz-tead 단백질-단백질 상호작용 억제제로서의 바이아릴 유도체
CN104592211B (zh) 联苯类化合物及其用途
TWI860392B (zh) (2-乙醯胺基)硫代-β-D-吡喃半乳糖苷衍生物
TWI873165B (zh) (雜)芳基-甲基-硫代-β-D-吡喃半乳糖苷衍生物
CN105085429B (zh) 芳杂环类衍生物及其在药物上的应用
RS58892B1 (sr) Jedinjenja 3-aminocikloalkila kao inhibitori ror-gama-t i njihove upotrebe
CN112513021B (zh) RORγ拮抗剂及其在药物中的应用
WO2016112088A1 (en) Aryloxyacetylindoles and analogs as antibiotic tolerance inhibitors
JP6976691B2 (ja) 医薬組成物
CN102686587B (zh) 氮杂吲哚葡糖激酶激活剂
OA18228A (en) Heterobicyclic compounds and their use for the treatment of tuberculosis.
HK1239683B (en) Heterobicyclic compounds and their use for the treatment of tuberculosis
HK1239683A1 (en) Heterobicyclic compounds and their use for the treatment of tuberculosis
CN116354862A (zh) 取代的氮杂环类化合物及其在药物中的应用
EA047452B1 (ru) Биарильные производные в качестве ингибиторов белок-белкового взаимодействия yap/taz-tead
HK40050961B (zh) 咪唑并吡啶酮化合物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200115

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200115

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210119

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210622

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210729

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20211019

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20211110

R150 Certificate of patent or registration of utility model

Ref document number: 6976691

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250